Treatment of the rickets of cystinosis with 1-alpha-hydroxycholecalciferol. 1977

J M Gertner, and D P Brenton, and C E Dent, and M Domenech

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003554 Cystinosis A metabolic disease characterized by the defective transport of CYSTINE across the lysosomal membrane due to mutation of a membrane protein cystinosin. This results in cystine accumulation and crystallization in the cells causing widespread tissue damage. In the KIDNEY, nephropathic cystinosis is a common cause of RENAL FANCONI SYNDROME. Cystine Diathesis,Cystine Disease,Cystine Storage Disease,Cystinoses,Cystinosin, Defect of,Cystinosis, Nephropathic,Lysosomal Cystine Transport Protein, Defect Of,Nephropathic Cystinosis,Cystine Diatheses,Cystine Diseases,Cystine Storage Diseases,Cystinoses, Nephropathic,Defect of Cystinosin,Diatheses, Cystine,Diathesis, Cystine,Nephropathic Cystinoses,Storage Disease, Cystine,Storage Diseases, Cystine
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006887 Hydroxycholecalciferols Hydroxy analogs of vitamin D 3; (CHOLECALCIFEROL); including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3. Hydroxyvitamins D,Hydroxycholecalciferol
D000469 Alkaline Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.
D012279 Rickets Disorders caused by interruption of BONE MINERALIZATION manifesting as OSTEOMALACIA in adults and characteristic deformities in infancy and childhood due to disturbances in normal BONE FORMATION. The mineralization process may be interrupted by disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis, resulting from dietary deficiencies, or acquired, or inherited metabolic, or hormonal disturbances. Rachitis,Rachitides

Related Publications

J M Gertner, and D P Brenton, and C E Dent, and M Domenech
October 1982, Archives francaises de pediatrie,
J M Gertner, and D P Brenton, and C E Dent, and M Domenech
May 1977, Calcified tissue research,
J M Gertner, and D P Brenton, and C E Dent, and M Domenech
June 1978, Polskie Archiwum Medycyny Wewnetrznej,
J M Gertner, and D P Brenton, and C E Dent, and M Domenech
February 1977, British medical journal,
J M Gertner, and D P Brenton, and C E Dent, and M Domenech
July 1976, Harefuah,
J M Gertner, and D P Brenton, and C E Dent, and M Domenech
January 1982, Revista clinica espanola,
J M Gertner, and D P Brenton, and C E Dent, and M Domenech
January 1980, Acta medica Scandinavica,
J M Gertner, and D P Brenton, and C E Dent, and M Domenech
June 1972, Archives of internal medicine,
J M Gertner, and D P Brenton, and C E Dent, and M Domenech
October 1976, British medical journal,
J M Gertner, and D P Brenton, and C E Dent, and M Domenech
September 1976, Clinical endocrinology,
Copied contents to your clipboard!